Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Semaglutide is a selective GLP-1 receptor agonist widely studied in metabolic and endocrinology research
Ismails group found that LC supplementation along with clomiphene citrate treatment improved both ovulation (64.4% vs.17.4%
Terzepatide has a dual-action mechanism (GLP-1 and GIP), while semaglutide only involves GLP-1 receptors
Patients should never discontinue GLP-1 medications without medical guidance, as abrupt cessation may lead to worsening glycemic control or weight regain
US$ 27.28
US$ 25.66
US$ 26.10
US$ 25.17
US$ 28.71
